Priscila Santiago Liberato de Mattos
( out of 16 reviews )

Priscila Santiago Liberato de Mattos, MD

Languages spoken: English, Portuguese, Spanish

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
Salt Lake City
801-587-4700
Directions

South Jordan Health Center

Gastroenterology
South Jordan
801-213-9797
Directions

Gastroenterology /GI Clinic UUH

Gastroenterology, Area E
Salt Lake City
801-213-9797
Directions

  • Priscila Santiago M.D., is an Assistant Professor of Medicine at the University of Utah School of Medicine in the Division of Gastroenterology, Hepatology and Nutrition, and specializes in Inflammatory Bowel Diseases.

    Dr. Santiago attended medical school at the Universidade Federal da Bahia in Brazil, graduating summa cum laude. She completed Internal Medicine residency training at the University of Miami, and Gastroenterology and Hepatology fellowship at Mayo Clinic Rochester, where she received the Eugenie Bolz Award for Excellence in Patient Care. She subsequently completed an advanced fellowship in Inflammatory Bowel Diseases (IBD) at Mayo Clinic - Rochester.

    Her clinical expertise includes diagnosing and managing patients with Inflammatory Bowel Diseases such as Crohn's disease and ulcerative colitis. She is dedicated to providing compassionate, inclusive, and personalized patient care. In addition to her clinical work, Dr. Santiago is actively involved in clinical research. Her research interests include inflammatory pouch diseases, the overlap between IBD and primary sclerosing cholangitis, and emerging therapies in IBD.

    Dr. Santiago is board certified in Gastroenterology. She is a member of the American Gastroenterological Association, the American College of Gastroenterology (Diversity, Equity, and Inclusion committee member), the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    Educational Commission for Foreign Medical Graduates
    National Board of Medical Examiners

    Patient Rating

    5.0 /5
    ( out of 16 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    December 01, 2024
    UH HOSPITALS AND CLINICS

    Very impressive doctor. She answered all my questions and was very thorough.

    November 29, 2024
    UH HOSPITALS AND CLINICS

    Top notch care

    November 14, 2024
    UH HOSPITALS AND CLINICS

    Highly recommend Dr. Santiago! Thank you for the treatment plan

    November 11, 2024
    UH HOSPITALS AND CLINICS

    Dr Santiago listens and cares about people. She addressed my concerns and fears and I was very comfortable with her knowledge and treatment plan. She explained everything thoroughly to me and listened to my feelings after. Amazing bedside manner. I left feeling like she really cared.

    November 08, 2024
    UH HOSPITALS AND CLINICS

    I was was very impressed with her knowledge and concern

    October 03, 2024
    UH HOSPITALS AND CLINICS

    I was very happy Dr. Santiago. She was patient, kind, didn't hurry us and answered all my questions (and there were a lot). I have been trying to find a doctor that I feel is looking out for me and my daughter and Dr. Santiago was wonderful.

  • Priscila Santiago M.D., is an Assistant Professor of Medicine at the University of Utah School of Medicine in the Division of Gastroenterology, Hepatology and Nutrition, and specializes in Inflammatory Bowel Diseases.

    Dr. Santiago attended medical school at the Universidade Federal da Bahia in Brazil, graduating summa cum laude. She completed Internal Medicine residency training at the University of Miami, and Gastroenterology and Hepatology fellowship at Mayo Clinic Rochester, where she received the Eugenie Bolz Award for Excellence in Patient Care. She subsequently completed an advanced fellowship in Inflammatory Bowel Diseases (IBD) at Mayo Clinic - Rochester.

    Her clinical expertise includes diagnosing and managing patients with Inflammatory Bowel Diseases such as Crohn's disease and ulcerative colitis. She is dedicated to providing compassionate, inclusive, and personalized patient care. In addition to her clinical work, Dr. Santiago is actively involved in clinical research. Her research interests include inflammatory pouch diseases, the overlap between IBD and primary sclerosing cholangitis, and emerging therapies in IBD.

    Dr. Santiago is board certified in Gastroenterology. She is a member of the American Gastroenterological Association, the American College of Gastroenterology (Diversity, Equity, and Inclusion committee member), the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    Educational Commission for Foreign Medical Graduates
    National Board of Medical Examiners

    Education history

    Fellowship Inflammatory Bowel Diseases - Mayo Clinic College of Medicine & Science Advanced Fellow
    Fellowship Gastroenterology and Hepatology - Mayo Clinic College of Medicine & Science Fellow
    Residency Internal Medicine - University of Miami Leonard M. Miller School of Medicine, Jackson Memorial Hospital Resident
    Other Training Science Without Borders Scholarship Program - Biomedical Sciences - University of New South Wales
    Professional Medical Medicine - Faculdade de Medicina de Bahia, Universidade Federal da Bahia M.D.

    Selected Publications

    Journal Article

    1. Santiago P, Coelho-Prabhu N, Lennon R, Rui S, Rajauria P, Friton J, Raffals LE, Deepali F, Daoud N, Farraye FA, Tuck J, Malik T, Leleiko NS, Shapiro J, Shah SA, Sands BE, Ungaro RC (2023). Baseline Clinical Factors are Associated with Risk of Complications in Crohn's Disease: Appraisal of the AGA Clinical Care Pathway. Am J Gastroenterol. (Read full article)
    2. Santiago P, Barnes EL, Raffals LE (2023). Classification and Management of Disorders of the J Pouch. Am J Gastroenterol. (Read full article)
    3. Guerrero Vinsard D, Bruining DH, East JE, Ebner D, Kane SV, Kisiel JB, Leighton JA, Lennon RJ, Loftus EV Jr, Malik T, Picco M, Raffals L, Ramos GP, Santiago P, Coelho-Prabhu N (2022). Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointest Endosc, 97(4), 790-798.e2. (Read full article)
    4. Aniwan S, Santiago P, Loftus EV Jr, Park SH (2022). The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United European Gastroenterol J, 10(10), 1063-1076. (Read full article)
    5. Santiago P, Braga-Neto MB, Loftus EV (2022). Novel Therapies for Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y), 18(8), 453-465. (Read full article)
    6. Santiago P, Levy C (2020). Novel Therapies for Managing Cholestasis. Clin Liver Dis (Hoboken), 15(3), 95-99. (Read full article)
    7. Sedki M, Fonseca N, Santiago P, Diaz L, Garcia-Buitrago M, Mirsaeidi M, Levy C (2019). Hepatic Sarcoidosis: Natural History and Management Implications. Front Med (Lausanne), 6, 232. (Read full article)
    8. Santiago P, Schwartz I, Tamariz L, Levy C (2019). Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis. Aliment Pharmacol Ther, 49(7), 830-839. (Read full article)
    9. Santiago P, Scheinberg AR, Levy C (2018). Cholestatic liver diseases: new targets, new therapies. Therap Adv Gastroenterol, 11, 1756284818787400. (Read full article)
    10. Baysari MT, Jackson N, Ramasamy S, Santiago P, Xiong J, Westbrook J, Omari A, Day RO (2016). Exploring sub-optimal use of an electronic risk assessment tool for venous thromboembolism. Appl Ergon, 55, 63-69. (Read full article)
    11. Mattos P, Santiago MB (2011). Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review. Clin Rheumatol, 30(2), 165-71. (Read full article)